Skip to main content

How Killer T Cells Find and Kill HIV

Understanding Immunotherapy: How Killer T Cells Destroy HIV

Cytotoxic T cells, commonly known as Killer T cells, serve as the body’s primary defense mechanism against internal threats. Unlike antiviral medications that focus on suppressing viral replication, immunotherapy leverages these cells to physically eliminate infected units.

The Search and Identify Process

Killer T cells circulate continuously through the bloodstream, patrolling for cellular abnormalities. The process follows a specific sequence:

  • Scanning: The T cell interacts with various cells to verify their health status.
  • Recognition: If a cell presents a foreign antigen—such as one infected by HIV—the Killer T cell binds to it securely.
  • Recruitment: Upon binding, the T cell emits chemical signals to alert and recruit additional white blood cells to the site.

The Elimination Mechanism

Once a target is identified, the Killer T cell initiates a two-step destructive process:

  1. Perforation: It releases perforin, a protein that punctures the membrane of the infected cell, creating physical pores.
  2. Neutralization: It injects granzymes (cytotoxic proteins) through these pores. This triggers the complete breakdown of both the host cell and the viral proteins contained within.

Immunotherapy vs. Antiviral Drugs

Standard antiviral therapies are designed to inhibit the virus’s ability to replicate, keeping the viral load in check. In contrast, immunotherapy aims for the total destruction of infected cells. By utilizing the Killer T cell’s natural ability to dismantle viral structures at a molecular level, this approach offers a fundamentally different outcome than traditional suppression.